Literature DB >> 30479480

Thyroid transcription factor-1 expression in invasive and non-invasive urothelial carcinomas.

S Sotiriou1, N Koletsas2, T Koletsa1, S Touloupidis3, M Lambropoulou4.   

Abstract

BACKGROUND: Thyroid transcription factor-1 (TTF-1) has been considered a sensitive marker for thyroid and lung tumors. Recent data have shown that a wide range of neoplasms may express TTF-1. CASE SERIES: We performed an immunohistochemical study in a case series of 42 urothelial carcinomas (UCs) on tissue microarrays sections, in order to investigate how often UCs express the TTF-1 protein and the diagnostic utility of this marker. In addition, we sought to determine by immunohistochemistry if there is an association between TTF-1 expression and the expression of specific basal-like or luminal markers. Five out of the 42 cases (11.9 %) were positive for TTF-1. Three positive tumors concerned non-invasive papillary UCs. There was no association between TTF-1 expression and tumor grade (χ2, p =0.419), stage (χ2, p =0.550) or cytokeratin 5/6 (χ2, p =0.330), cytokeratin 20 (χ2, p =0.995) and estrogen receptors expression (χ2, p =0.268).
CONCLUSIONS: UCs may show TTF-1 expression and pathologists should be aware of this phenomenon in order to avoid misdiagnosis, notably in metastatic disease. HIPPOKRATIA 2017, 21(3): 154-157.

Entities:  

Keywords:  Thyroid transcription factor-1; cytokeratin 20; cytokeratin 5/6; estrogen receptors; immunohistochemistry; metastatic lung tumor; urothelial neoplasm

Year:  2017        PMID: 30479480      PMCID: PMC6248004     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  15 in total

1.  Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.

Authors:  O Kaufmann; M Dietel
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

Review 2.  Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-10

3.  Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.

Authors:  D Penman; I Downie; F Roberts
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  TTF-1 expression in breast carcinoma: an unusual but real phenomenon.

Authors:  Yun-Bi Ni; Julia Y S Tsang; Mu-Min Shao; Siu-Ki Chan; Joanna Tong; Ka-Fai To; Gary M Tse
Journal:  Histopathology       Date:  2013-11-25       Impact factor: 5.087

5.  Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.

Authors:  Ma Jesús Fernández-Aceñero; Sharon Córdova; Félix Manzarbeitia; Camino Medina
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

6.  Thyroid transcription factor-1 in primary CNS tumors.

Authors:  Marianne Højsgaard Kristensen; Søren Nielsen; Mogens Vyberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-10

7.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

8.  TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.

Authors:  Paul J Zhang; Hong G Gao; Theresa L Pasha; Leslie Litzky; Virginia A Livolsi
Journal:  Int J Gynecol Pathol       Date:  2009-01       Impact factor: 2.762

9.  Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique.

Authors:  Jose Antonio Plaza; David Suster; Delia Perez-Montiel
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

10.  The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.

Authors:  Judit Moldvay; M Jackel; K Bogos; I Soltész; L Agócs; G Kovács; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

View more
  1 in total

1.  Pure small cell neuroendocrine carcinoma of urinary bladder: A case report.

Authors:  Abbas Eshraghi; Mohammad Mehdi Riyahi; Afshin Ghaderi; Maedeh Alsadat Fatemi; Azhar Eshraghi; Danial Fazilat-Panah
Journal:  Clin Case Rep       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.